Published in AJNR Am J Neuroradiol on October 20, 2011
¹⁸F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility. Eur J Nucl Med Mol Imaging (2015) 1.43
Perfusion MRI: the five most frequently asked technical questions. AJR Am J Roentgenol (2013) 1.21
Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors. Mol Imaging (2014) 1.04
Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol (2013) 0.88
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives. Adv Ther (2016) 0.84
Advanced techniques using contrast media in neuroimaging. Magn Reson Imaging Clin N Am (2012) 0.81
Three-dimensional susceptibility-weighted imaging at 7 T using fractal-based quantitative analysis to grade gliomas. Neuroradiology (2012) 0.80
Assessment of diffusion tensor imaging metrics in differentiating low-grade from high-grade gliomas. Neuroradiol J (2016) 0.77
Conventional and advanced (DTI/SWI) neuroimaging findings in pediatric oligodendroglioma. Childs Nerv Syst (2015) 0.76
Exploring the biomechanical properties of brain malignancies and their pathologic determinants in vivo with magnetic resonance elastography. Cancer Res (2015) 0.76
MR-guided radiation therapy: transformative technology and its role in the central nervous system. Neuro Oncol (2017) 0.75
High-grade glioma management and response assessment-recent advances and current challenges. Curr Oncol (2016) 0.75
Advanced neuroimaging in the clinic: critical appraisal of the evidence base. Br J Radiol (2016) 0.75
Gadobutrol in India-A Comprehensive Review of Safety and Efficacy. Magn Reson Insights (2017) 0.75
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS (1998) 8.88
Apolipoproteins and ischaemic heart disease: implications for screening. Lancet (1994) 6.62
Anterior opercular cortex lesions cause dissociated lower cranial nerve palsies and anarthria but no aphasia: Foix-Chavany-Marie syndrome and "automatic voluntary dissociation" revisited. J Neurol (1993) 3.70
Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med (2001) 3.55
Insertional mutagenesis of genes required for seed development in Arabidopsis thaliana. Genetics (2001) 3.49
Use of personal medical records for research purposes. BMJ (1994) 3.29
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine. Oncogene (2006) 2.82
MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics. AJNR Am J Neuroradiol (2008) 2.76
Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol (2008) 2.74
A primary genetic linkage map for human chromosome 12. Genomics (1987) 2.72
How effective is nicotine replacement therapy in helping people to stop smoking? BMJ (1994) 2.68
Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med (2003) 2.60
The prediction of criminal and violent recidivism among mentally disordered offenders: a meta-analysis. Psychol Bull (1998) 2.60
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology (2007) 2.47
Prognostic significance of blood pressure variability after thrombolysis in acute stroke. Neurology (2008) 2.45
An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet (2003) 2.43
The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol (2001) 2.42
Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res (2001) 2.26
CD8+ lymphocyte responses to antiretroviral therapy of HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 2.23
An appraisal of the efficacy and cost effectiveness of antenatal screening for hepatitis B. J Med Screen (1997) 2.12
Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol (2000) 2.10
Vaccinia virus utilizes microtubules for movement to the cell surface. J Cell Biol (2001) 2.10
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat Med (1995) 2.08
New diagnostic criteria for multiple sclerosis: application in first demyelinating episode. Neurology (2003) 2.04
[Effectiveness of smoking cessation intervention in patients with cardiovascular disease]. Rev Esp Cardiol (2001) 1.93
Letter: Unusual cardiac and neurological reactions to narcotics. Lancet (1973) 1.90
MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90
Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis. Scand J Rheumatol (2008) 1.84
The role of initial AIDS-defining illness in survival following AIDS. AIDS (1995) 1.82
CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. Science (2000) 1.77
3D time-resolved MR angiography (MRA) of the carotid arteries with time-resolved imaging with stochastic trajectories: comparison with 3D contrast-enhanced Bolus-Chase MRA and 3D time-of-flight MRA. AJNR Am J Neuroradiol (2008) 1.74
Semiconductor quantum dots and quantum dot arrays and applications of multiple exciton generation to third-generation photovoltaic solar cells. Chem Rev (2010) 1.72
Pituitary enlargement in patients with intracranial hypotension syndrome. Neurology (2000) 1.71
Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol (2005) 1.69
Turnover of protein-bound phosphorylserine in membrane preparations from ox brain catalysed by intrinsic kinase and phosphatase activity. Biochem J (1971) 1.68
Screening, ethics, and the law. BMJ (1992) 1.67
Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol (1994) 1.67
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63
Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol (2010) 1.63
Prognostic factors in hormone-resistant progressing cancer of the prostate. Ann Oncol (1992) 1.61
Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol (2001) 1.61
Measuring children's participation in recreation and leisure activities: construct validation of the CAPE and PAC. Child Care Health Dev (2007) 1.61
Protein kinase activity in membrane preparations from ox brain. Stimulation of intrinsic activity by adenosine 3':5'-cyclic monophosphate. Biochem J (1973) 1.59
Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Res (2001) 1.58
Optical detection of liquid-state NMR. Nature (2006) 1.57
Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci (1996) 1.56
Lumbar extradural hemangiomas: report of three cases. AJNR Am J Neuroradiol (1999) 1.55
Primary central nervous system lymphomas (PCNSL): MRI response criteria revised. Neurology (2005) 1.52
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas. Leukemia (2008) 1.51
Iridoschisis and keratoconus. Cornea (1994) 1.50
Expression and functional activity of osteoprotegerin in human malignant gliomas. Acta Neuropathol (2003) 1.49
Measures in the first year of therapy predict the response to interferon beta in MS. Mult Scler (2009) 1.49
Short rib-polydactyly (SRP) syndromes, types Majewski and Saldino-Noonan. Z Kinderheilkd (1974) 1.48
Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note. Acta Neuropathol (1999) 1.48
Palpatory method used to identify the recurrent laryngeal nerve during thyroidectomy. World J Surg (2000) 1.48
Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother Oncol (1997) 1.47
The effects of obesity and HER-2 polymorphisms as risk factors for endometrial cancer in Korean women. BJOG (2009) 1.46
Arabidopsis genes essential for seedling viability: isolation of insertional mutants and molecular cloning. Genetics (2001) 1.46
Primary central nervous system (CNS) lymphoma in immunocompetent patients. Ann Hematol (2002) 1.46
Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis. Ann Neurol (1998) 1.45
Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc Natl Acad Sci U S A (2001) 1.45
Baseline MRI predicts future attacks and disability in clinically isolated syndromes. Neurology (2006) 1.42
Does clozapine cause neuroleptic malignant syndrome? J Clin Psychiatry (1993) 1.41
Magnetic repulsion of linear accelerator contaminates. Med Phys (1996) 1.41
Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group. J Infect Dis (1998) 1.41
Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer (2011) 1.41
Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri. AJNR Am J Neuroradiol (2002) 1.40
MRI features of primary central nervous system lymphomas at presentation. Neurology (2001) 1.40
Efficacy of DNA and fowlpox virus priming/boosting vaccines for simian/human immunodeficiency virus. J Virol (2004) 1.39
[Body mass index influence in the insulin action mechanisms]. An Med Interna (1998) 1.38
Elevated levels of fibronectin in the CSF: what do they signify? J Neurol Sci (1992) 1.38
[The development of multiple sclerosis following an isolated episode of optic neuritis. Magnetic resonance study]. Med Clin (Barc) (1997) 1.37
Isolation and characterization of mouse mesenchymal stem cells. Transplant Proc (2008) 1.37
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma. Neurology (2004) 1.36
HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Med (2003) 1.34
Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun (1999) 1.33
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer. Ann Oncol (2011) 1.33
Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J Neurooncol (2001) 1.33
APO2 ligand: a novel lethal weapon against malignant glioma? FEBS Lett (1998) 1.32
Health-related quality of life in childhood epilepsy: the results of children's participation in identifying the components. Dev Med Child Neurol (1999) 1.31
Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res (1999) 1.31
Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc Res Tech (2001) 1.30
Accuracy of the Alberta Stroke Program Early CT Score during the first 3 hours of middle cerebral artery stroke: comparison of noncontrast CT, CT angiography source images, and CT perfusion. AJNR Am J Neuroradiol (2008) 1.30
BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J Neurol Neurosurg Psychiatry (1999) 1.29
Stimulation by cyclic AMP of intrinsic protein kinase activity in ox brain membrane preparations. Nature (1970) 1.29
A comparison of adjuvant psychological therapy and supportive counselling in patients with cancer. Psychooncology (1998) 1.29
Caspases as treatment targets in stroke and neurodegenerative diseases. Ann Neurol (1999) 1.28
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology (2010) 1.27
Linking perceptions of neighbourhood to health in Hamilton, Canada. J Epidemiol Community Health (2004) 1.27
Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer (2005) 1.26
Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur J Immunol (1995) 1.26
Diffusion tensor imaging in multiple sclerosis: assessment of regional differences in the axial plane within normal-appearing cervical spinal cord. AJNR Am J Neuroradiol (2006) 1.26
CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Oncogene (2003) 1.26
Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene (2000) 1.26
Comparing explorative saccade and flicker training in hemianopia: a randomized controlled study. Neurology (2009) 1.25
Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Br J Dermatol (2004) 1.24
Breaking symmetry: the marine environment, prey size, and the evolution of asymmetry in cetacean skulls. Anat Rec (Hoboken) (2007) 1.22
Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients. Br J Radiol (1993) 1.22